Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Follow Bar and Bench channel on WhatsApp

Download the Bar and Bench Mobile app for instant access to the latest legal news.

Also Read

Denial of passover not ground for review of judgment: Delhi High Court in Alapan Bandyopadhyay case

Cyber crimes cause financial and emotional damage: CJI Surya Kant

Jharkhand HC grants bail to man who claimed he was framed after he objected to loud music on train

Jharkhand High Court drops contempt case against lawyer who told judge not to cross limits

State of the Law: Regulating cryptocurrency - The challenge of fitting a square peg into traditional round holes

SCROLL FOR NEXT